ACOR
Acorda Therapeutics
ACOR
ACOR
Delisted
ACOR was delisted on the 11th of April, 2024.
176 hedge funds and large institutions have $1.23B invested in Acorda Therapeutics in 2015 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 69 increasing their positions, 50 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
75% less call options, than puts
Call options by funds: $2.15M | Put options by funds: $8.69M
Holders
176
Holding in Top 10
2
Calls
$2.15M
Puts
$8.69M
Top Buyers
| 1 | +$28.7M | |
| 2 | +$21.2M | |
| 3 | +$15M | |
| 4 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
+$13.5M |
| 5 |
Millennium Management
New York
|
+$11.3M |
Top Sellers
| 1 | -$46M | |
| 2 | -$22.7M | |
| 3 | -$11.2M | |
| 4 |
Renaissance Technologies
New York
|
-$9.48M |
| 5 |
Jennison Associates
New York
|
-$9.01M |